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INTRODUCTION:  Standard  surgical  approach  for advanced  breast  cancer  is  a modiﬁed  radical  mastectomy
with  a periareolar  elliptical  incision.  Here  a unique  surgical  approach  is  presented  utilizing  intraoperative
real  time  tissue  perfusion  technology.
PRESENTATION OF CASE:  A 65-year  old  African  American  female  was  diagnosed  with  grade  3  papillary
carcinoma  on  biopsy  of a  palpable  3.7  cm left breast  mass  at 12 o’clock  position.  Pathology  showed  a
T2N0M0  invasive  ductal  carcinoma,  triple  negative  disease,  with  clear  margins.  Patient  opted  for  natur-
opathic  treatment.  Six months  later,  cancer  recurred  at  the  local  site;  the  patient  persisted  with  natural
remedies.  Nine  months  later,  the  mass  had  progressed  to 14.5 cm with  smaller  adjacent  nodules  and
nodular  thickening  of  breast  with  no  metastatic  disease.  Patient  received  neoadjuvant  chemoradiation.
Ten  months  later,  patient  underwent  a nipple-sparing  radical  mastectomy  given  the persistent  pectoral
muscle  involvement  of  this  mass.
DISCUSSION: An  elliptical  incision  was  made  in  the  superior  aspect  of  the breast  wall  at  least  6 cm  above
the  areola.  After  tumor  removal,  the  skin  edges  were  approximated.  It was  decided  preoperatively  to  use
TMthe  SPY  Elite system  to  assess  perfusion  of  the  ﬂap  edges.  Angiography  with  indocyanine  green  showed
poor  perfusion  of  the  inferior  ﬂap and  an additional  2  cm  of  skin  was  resected.  Final  pathology  showed
that  all  margins  were  clear  of  disease  and  patient  recovered  well  from  surgery.
CONCLUSION: This  case  study  shows  that  an individualized  approach  resulted  in  an  optimal  outcome  for
the  patient.  The  infrequent  procedure  of  a nipple-sparing  radical  mastectomy  was  done  in  coordination
TM e  goo
blish
-SA licwith  SPY Elite to achiev
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. Introduction
The standard surgical approach for advanced breast cancer is a
odiﬁed radical mastectomy.1,2 A modiﬁed radical mastectomy is
 procedure in which the entire breast is removed; including the
kin, areola, nipple, and level I and level II axillary lymph nodes,
ut the pectoralis major muscle is spared.3 In breast cancer cases
ith pectoral muscle involvement a radical mastectomy may  need
Open access under CC BY-NCo be done if there is persistence of disease despite neoadjuvant
hemoradiation.
In a radical mastectomy all of the breast tissue along with the
ipple, lymph nodes in the axilla, and chest wall muscles, under
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the breast are removed.4 Due to the invasive nature of the proce-
dure higher incidence of post-operative complications are likely.
The cause of these early complications is often attributed to inade-
quate tissue perfusion.5 Surgeons have relied on vision and clinical
judgment to evaluate tissue perfusion.6 While experienced sur-
geons are often comfortable making this assessment, it remains
subjective and can be difﬁcult in certain situation.7
The SPY EliteTM intraoperative perfusion assessment system as
shown in Fig. 1 is an imaging system used as an adjunctive method
for the evaluation of tissue perfusion in surgical procedures where
additional perfusion information is needed.8 The SPY EliteTM sys-
tem provides objective, intraoperative assessment of blood ﬂow
to tissues, allowing for immediate surgical changes that can lead
to improved wound healing and reduce the risk for postoperative
conditions. The system utilizes the ﬂuorescent agent indocyanine
green (ICG). ICG is a sterile, water soluble tricarbocyanine dye with
a peak spectral absorption at 800–810 nm.  ICG binds tightly to
ense.plasma proteins and has a short half-life of 2.5–3 min allowing for
repeat evaluations during the surgical procedures.8
The SPY EliteTM intraoperative perfusion assessment system
is available in the United States and Canada. It is distributed by
s Ltd. Open access under CC BY-NC-SA license.
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in its lateral aspect as shown in Fig. 3. Superior and inferior skin
ﬂaps were raised. There were dense adhesions of the skin to the
upper ﬂap area and given the concern that there could be tumorFig. 1. Image of the SPY EliteTM system.
ifeCell and manufactured by Novadaq. The system is cost effective
ecause most hospitals view the complications that can arise when
ot using the device to far exceed the cost of the device.9
This study illustrates the use of the SPY EliteTM system to assess
ap viability following a nipple-sparing radical mastectomy with
n unusual incision site.
.  Presentation of case
A  65-year old African American female was  diagnosed with
rade 3 papillary carcinoma on biopsy of a palpable 3.7 cm left
reast mass at 12 o’clock position in April 2009. In June 2009
he underwent a left partial mastectomy with sentinel node
iopsy. Pathology showed stage T2N0MX ductal carcinoma that
as ER/PR and HER-2/neu negative with clear margins. The patient
as advised chemotherapy by her initial treating oncologist but
efused conventional treatment and opted for naturopathic treat-
ent engaging in vitamin and dietary supplements. In December
010 the patient felt a new lump in left breast. A mammogram
howed a 6 cm mass at the 1 o’clock position. A biopsy showed
nvasive high grade ductal carcinoma with papillary features,
R/PR and HER-2/neu negative. The patient was  advised neoad-
uvant chemotherapy followed by a mastectomy. The patient again
efused treatment and continued with her naturopathic treatment.
he mass continued to grow occupying almost the entire left breastFig. 2. Pathology showing a T2N0M0 invasive ductal carcinoma, triple negative
disease,  with clear margins extraction.
with increasing pressure and pain. In September 2011 the patient
presented to our facility.
A  CT scan revealed a 14.5 cm × 9.5 cm mass in the left breast
extending toward the axillary with smaller adjacent nodules and
slight nodular thickening of the skin with no metastatic disease.
Multiple dilated vessels were seen in the left breast. Pathology
conﬁrmed a stage T2N0MX ductal carcinoma that was  ER/PR and
HER-2/neu negative with clear margins as shown in Fig. 2. Although
this was  a triple negative disease, the patient was advised neoadju-
vant chemotherapy followed by a mastectomy to potentially avoid
resecting the pectoralis muscle during the mastectomy. The patient
received six cycles of 365 mg  of Carboplatin and 100 mg  of Tax-
otere from September 2011 to March 2012. During this time the
patient had a break in chemotherapy due to neutropenia and for
going on vacation. The patient also received radiation therapy to the
left breast. From April 2012 to May  2012 the patient got 5000 cGy
to the left breast in 25 fractions. In July 2012, given the mass still
involved the pectoral muscle despite some response to neoadjuvant
chemo and radiation therapy, a left nipple-sparing radical mastec-
tomy with axillary dissection was  performed in coordination with
the SPY EliteTM system for assessing ﬂap perfusion by injection of
ICG under general anesthesia.
The patient was  prepped and draped in the standard fashion.
An elliptical incision was  made, above the nipple areola from the
lateral edge of the sternal border and pointing toward the axillaFig. 3. Intra-operative image of the nipple-sparing radical mastectomy and speci-
men extraction.
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nig. 4. Lower pole of breast imaged with the SPY EliteTM system to assess tissue
erfusion.
nvolvement, multiple frozen sections were done and all were neg-
tive for malignancy.
The  tumor was high up in the chest wall approximately 4 cm
elow the level of clavicle and was involving the pectoral mus-
le. The superior portion of the chest wall was dissected down to
he level of the chest wall by going through the pectoralis mus-
le. The pectoralis major muscle was resected and the breast tissue
as taken off the serratus anterior muscle inferiorly. The inferior
nvelope of the breast skin and nipple were spared and this helped
n the closure of the wound later. Frozen section of the breast tis-
ue from just under the nipple was also negative for malignancy.
 14.5 cm × 9.5 cm specimen was removed with a thin portion of
kin. Axillary dissection was done. Two number ﬁfteen Blake drains
ere placed, one in the axilla, and the other in the left anterior
hest.
Although clinically the margins appeared well-perfused, it was
ecided preoperatively to use the SPY EliteTM imaging system to
apture and view ﬂuorescence images for the visual assessment
f blood ﬂow as an adjunctive method for the evaluation of tissue
erfusion.8 The imaging head of the SPY EliteTM machine as shown
n Fig. 1 was positioned at the correct distance from the patient
o achieve optimal imaging. Using a three way stopcock attached
o an injection port on the infusion line the prepared 2.5 mg/ml
CG solution was injected as a tight bolus. The access on the stop-
ock was then switched to the syringe containing saline to briskly
ush the ICG bolus through the line with 10 ml  of sterile saline to
chieve optimal image quality. The lower pole of the breast was
hen imaged as shown in Fig. 4. The 100 percent mark was  placed
n an area of undamaged skin where there was good perfusion.
he numbers reﬂect the percentage of perfusion relative to the 100
ercent marker. Angiography with indocyanine green showed poor
erfusion of the inferior ﬂap quantiﬁed by the 15 and 25 percent
arks as shown in Fig. 4. As a result, an additional 2 cm of skin of the
nferior ﬂap was resected and then approximated with the superior
ap. After resection this border was rechecked for perfusion. The
PY EliteTM imaging system showing marked improvement in the
ascularity of the ﬂap.
The  dermis was closed with multiple interrupted 3-0 Vicryl
utures, and the skin was approximated with running continuous
-0 Monocryl in a subcuticular fashion. Dermabond was  applied on
op of the incision.
There  were no complications during the procedure, and the
atient recovered well from surgery. The patient was  discharged
ome at day one following surgery. At the last follow-up in August
013, thirteen months after surgery, CT and PET scan images
howed no evidence of recurrent disease. The patient did not
eceive post-operative radiotherapy or chemotherapy as there was
o recurrent disease.Fig. 5. Postoperative image after nipple-sparing radical mastectomy.
3. Discussion
This case study shows that an individualized approach resulted
in an optimal outcome for the patient. The infrequent proce-
dure of a nipple-sparing radical mastectomy was  done, with an
unusual elliptical incision made in the superior aspect of the
breast wall at least 6 cm above the areola as shown in Fig. 3. The
SPY EliteTM intraoperative tissue perfusion assessment system to
assess ﬂap viability was  used successfully to ﬁnd a viable ﬂap
edge to promote optimal wound healing although clinical judg-
ment erroneously suggested that the initial ﬂap edges were well
perfused.
Fluorescence angiography with ICG is a sensitive diagnos-
tic tool for detecting compromised tissue perfusion in trauma
surgery and microsurgery.10 The SPY EliteTM system allowed the
surgeon to compare areas of good tissue perfusion in undam-
aged skin to areas of poor perfusion. In this case the SPY
EliteTM system showed poor perfusion in the inferior ﬂap of
the breast leading to an additional 2 cm being resected result-
ing in improved perioperative management and better clinical
results.
Final pathology showed that all margins were clear of disease
and there was  no lymph node involvement. The patient recovered
well from surgery with satisfactory wound healing and a good
cosmetic result with minimal scarring as shown in Fig. 5. With
intraoperative imaging, the surgeon is provided with an on-table
assessment of breast skin perfusion that facilitates identiﬁcation
and removal of poorly perfused tissue that results in decreases
complication rates.5
4. Conclusion
In this case study we  illustrate the use of a tissue per-
fusion assessment system to assess ﬂap viability in a patient
undergoing a nipple-sparing radical mastectomy with an unusual
incision site. This study shows that uncommon surgical prac-
tices can be performed successfully when technology is used to
complement good clinical judgment in assessing tissue perfu-
sion.
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